BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20046078)

  • 21. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
    You E; Park CJ; Lee MY; Cho YU; Jang S; Lee JH; Lee JH; Lee KH
    Int J Med Sci; 2023; 20(2):206-210. PubMed ID: 36794163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
    Ko YH; Park S; Kim K; Kim SJ; Kim WS
    Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.
    Salama ME; Parham DM; Perkins SL; Bahler DW; Ellison DA
    Pediatr Dev Pathol; 2008; 11(6):443-9. PubMed ID: 18473605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
    Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
    Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive NK cell leukaemia after splenectomy: association with CD95-resistant memory T-cell proliferation and recalcitrant clinical course of haemophagocytic syndrome.
    Suzuki S; Uozumi K; Utsunomiya A; Ishitsuka K; Masamoto I; Owatari S; Makino T; White Y; Arima N
    Eur J Haematol; 2008 Sep; 81(3):236-41. PubMed ID: 18510705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
    Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
    Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic Expression of CD3ε Heterodimers by Flow Cytometry Rapidly Distinguishes Between Mature T-Cell and Natural Killer-Cell Neoplasms.
    Shi M; Nguyen P; Timm MM; Otteson GE; Horna P; Olteanu H; Jevremovic D
    Am J Clin Pathol; 2020 Oct; 154(5):683-691. PubMed ID: 32589191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.
    Went P; Agostinelli C; Gallamini A; Piccaluga PP; Ascani S; Sabattini E; Bacci F; Falini B; Motta T; Paulli M; Artusi T; Piccioli M; Zinzani PL; Pileri SA
    J Clin Oncol; 2006 Jun; 24(16):2472-9. PubMed ID: 16636342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
    Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
    Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
    Kapur LH; Khaled Y; Solh M; Ward D; Chang CC
    Arch Pathol Lab Med; 2014 Jul; 138(7):969-73. PubMed ID: 24978925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature.
    Ruskova A; Thula R; Chan G
    Leuk Lymphoma; 2004 Dec; 45(12):2427-38. PubMed ID: 15621755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractions.
    Choi YL; Makishima H; Ohashi J; Yamashita Y; Ohki R; Koinuma K; Ota J; Isobe Y; Ishida F; Oshimi K; Mano H
    Leukemia; 2004 Mar; 18(3):556-65. PubMed ID: 14737071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis.
    Weisberger J; Cornfield D; Gorczyca W; Liu Z
    Am J Clin Pathol; 2003 Jul; 120(1):49-55. PubMed ID: 12866372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia.
    Tian Y; Kobayashi S; Ohno N; Isobe M; Tsuda M; Zaike Y; Watanabe N; Tani K; Tojo A; Uchimaru K
    Cancer Sci; 2011 Mar; 102(3):569-77. PubMed ID: 21205081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.